Halozyme Therapeutics (NASDAQ:HALO) fell 14% after confirming on Thursday that it made an €11 per share bid for Evotec .

A lot of rumors are starting to surface surrounding the first major crossovers for Call of Duty: Black Ops 6, such as a ...

In a recent interview, Microsoft Gaming CEO Phil Spencer had some compelling things to say about the future of the Halo ...